NSN 6505-01-475-3038, 6505014753038
HEPATITIS B VIRUS VACCINE,INACTI

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 014753038
Codification Country: United States
Item Name Code: INC 39170
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Readily Available Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-475-3038

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-475-3038

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-475-3038

National Stock Number (NSN) 6505-01-475-3038, or NIIN 014753038, (hepatitis b virus vaccine,inacti) was assigned May 31, 2000 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.

There are 3 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 2 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 2 suppliers are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over a year. There have been 10 contracts issued for this part number, with 17 awards given. There is minimal competition for this NSN. The US Government has awarded contracts to 3 different suppliers. The last contract numbers awarded were: SPE2D024F0025, SPE2D023F0410, SPE2DP21P0338, SPE2DX15D9383, SPE2DX15D9383. The total value of the awarded contracts has been US$ 14,558.88.

There has been a small amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 02, 2006, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 39170. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505014753038 does not contain precious metals.

This NSN is associated to Schedule B 3002200000: vaccines for human medicine. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325414: biological product (except diagnostic) manufacturing.

This information was last updated on Aug 01, 2025.

Technical Characteristics

III SUPPLEMENTARY FEATURES: (SUPP) RECOMMENDED VACCINATION REGIMENS CONSISTS OF 3 DOSES AT 5MCG EACH; TO BE ADMINISTERED AS FOLLOWS: FIRST DOSE AT ELECTED DATE; SECOND DOSE 1 MONTH LATER; THIRD DOSE 6 MONTHS AFTER THE FIRST DOSE
PROTECTIVE STORAGE FEATURE: (AJCN) REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
III PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) HEPATITIS B VIRUS VACCINE INACTIVATED MODIFIED SGL DOSE VIAL 10S
SUPPLEMENTARY FEATURES: (SUPP) ARECOMMENDED VACCINATION REGIMENS CONSISTS OF 3 DOSES AT 5MCG EACH; TO BE ADMINISTERED AS FOLLOWS: FIRST DOSE AT ELECTED DATE; SECOND DOSE 1 MONTH LATER; THIRD DOSE 6 MONTHS AFTER THE FIRST DOSE
IMMEDIATE CONTAINER QUANTITY: (ANNX) 10
IMMEDIATE CONTAINER TYPE: (ANNW) VIAL, SINGLE DOSE
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) HEPATITIS B VIRUS VACCINE INACTIVATED MODIFIED SGL DOSE VIAL 10S
MEDICAL DESIGNATION AND GRADE: (MDES) MODIFIED
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: (ANNY) 10DOSES AND 5MCG/0.5ML VIALS
SUPPLEMENTARY FEATURES: (SUPP) RECOMMENDED VACCINATION REGIMENS CONSISTS OF 3 DOSES AT 5MCG EACH; TO BE ADMINISTERED AS FOLLOWS: FIRST DOSE AT ELECTED DATE; SECOND DOSE 1 MONTH LATER; THIRD DOSE 6 MONTHS AFTER THE FIRST DOSE
SPECIAL FEATURES: (FEAT) VACCINE PRESERVATIVE FREE AND THIMEROSAL FREE;RECOMBIVAX HB (RECOMBINANT) IS FOR INTRAMUSCULAR INJECTION; FOR USE IN INFANTS, CHILDREN AND ADOLESCENTS (AGES 0-19); DOSAGE SUPPLIED AS 5 MCG/0.5 ML OF HBSAG (SURFACE ANTIGEN) IN A 0.5 ML SINGLE-DOSE VIAL; PACKAGE OR BOX OF 10; NO MORE THAN 1 PERCENT YEAST PROTEIN AND FREE OF ASSOCIATION WITH HUMAN BLOOD OR BLOOD PRODUCTS; SHAKE WELL BEFORE USE
UNIT PACKAGE TYPE: (AGXZ) PACKAGE
III IMMEDIATE CONTAINER TYPE: (ANNW) VIAL, SINGLE DOSE